Mutual Funds that own Abcam PLC
T Rowe Price New Horizons Fund
11,155,223
5.44%
-1,117,861
0.9%
06/30/2018
Oppenheimer International Small Company Fund
6,636,210
3.24%
0
1.24%
02/28/2018
T Rowe Price International Discovery Fund
5,589,215
2.73%
-1,006,507
1.24%
06/30/2018
Standard Life Investment Co. ICVC - UK Smaller Companies Fund
4,143,631
2.02%
0
3.89%
08/31/2018
GLG International ICVC - Esprit Continental Europe Fund
3,446,528
1.68%
0
3.12%
07/31/2018
Wasatch International Growth Fund
2,458,735
1.2%
0
2.86%
03/31/2018
Wasatch Small Cap Growth Fund
2,099,449
1.02%
-24,624
2%
03/31/2018
Wasatch Core Growth Fund
1,908,420
0.93%
0
1.82%
03/31/2018
American Funds Small Cap World Fund
1,900,000
0.93%
0
0.1%
06/30/2018
Neuberger Berman Genesis Fund
1,851,525
0.9%
-75,885
0.31%
06/30/2018
| Address |
330 Cambridge Science Park
Cambridge East Anglia CB4 0FL
United Kingdom
|
|
Employees
|
- |
| Website |
http://abcam.com |
| Updated |
07/08/2019 |
| Abcam Plc distributes antibodies and associated protein research tools. Its product includes primary and secondary antibodies, proteins, peptides, lysates, biochemicals, immunoassays and other kits. The company was founded by Adam Robert David Cleevely, Anthony Kouzarides and Jonathan Milner on February 12, 1998 and is headquartered in Cambridge, the United Kingdom. |
